Corbus Pharmaceuticals shares are trading higher after B. Riley Securities initiated coverage on the stock with a Buy rating and a price target of $85.
Portfolio Pulse from Benzinga Newsdesk
Corbus Pharmaceuticals shares are trading higher after B. Riley Securities initiated coverage on the stock with a Buy rating and a price target of $85.
June 26, 2024 | 1:35 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Corbus Pharmaceuticals shares are trading higher following a Buy rating and an $85 price target from B. Riley Securities.
The initiation of coverage with a Buy rating and a high price target by B. Riley Securities is a strong positive signal for investors, likely driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100